Regorafenib Vs Sorafenib in the Treatment of Liver Cancer

preview_player
Показать описание
Dr. Jordi Bruix, MD, head of the Barcelona Clinic Liver Cancer (BCLC) at University of Barcelona, discusses the major impact that regorafenib (Stivarga) and sorafenib (Nexavar) will have for the treatment of liver cancer.
  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Regorafenib Vs Sorafenib 0:01:11

Regorafenib Vs Sorafenib in the Treatment of Liver Cancer

Real Life Analysis 0:01:10

Real Life Analysis Shows Regorafenib Improves Survival Upon Progression on Sorafenib in HCC

Regorafenib and PD-1 0:02:22

Regorafenib and PD-1 inhibitor for a Sorafenib-Refractory HCC patient - Video abstract [ID 284092]

Debate: Is there 0:11:18

Debate: Is there a standard second line therapy for HCC? - Regorafenib is a winner

Dr. Finn on 0:01:34

Dr. Finn on the Promise of Regorafenib for the Treatment of HCC

Dr. Sherman on 0:01:27

Dr. Sherman on the Role of Regorafenib in Liver Cancer

Regorafenib in Advanced 0:03:11

Regorafenib in Advanced HCC

Dr. Daniele on 0:00:49

Dr. Daniele on Impact of Regorafenib in HCC

Comparative Efficacy of 0:03:56

Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma

Survival Benefit Confirmed 0:01:09

Survival Benefit Confirmed in Real-Life Analysis of Second-Line Regorafenib in HCC

REFINE: a real-world 0:02:52

REFINE: a real-world analysis of regorafenib in patients with unresectable HCC

Dr. Bruix on 0:02:04

Dr. Bruix on Regorafenib in Second-Line HCC

Regorafenib Following First-Line 0:04:30

Regorafenib Following First-Line Systemic Therapy in HCC

QoL analyses from 0:02:01

QoL analyses from RATIONALE-301 of tislelizumab vs sorafenib in HCC

Dr. O’Connor on 0:01:28

Dr. O’Connor on Real-World Results With Regorafenib in mCRC

Regorafenib and pembrolizumab 0:01:49

Regorafenib and pembrolizumab in pre-treated hepatocellular carcinoma

Managing Side Effects 0:01:51

Managing Side Effects With Regorafenib in HCC

Regorafenib in Colorectal 0:09:34

Regorafenib in Colorectal Cancer

Clinical Experience with 0:03:48

Clinical Experience with Regorafenib in HCC

Treatment Response and 0:02:58

Treatment Response and Side Effects with Regorafenib

Dr. Jordi Bruix 0:01:47

Dr. Jordi Bruix on the Impact Regorafenib Will Have on Liver Cancer Treatment

Adverse Events Inform 0:01:33

Adverse Events Inform Treatment Decisions in HCC for Frontline Lenvatinib Versus Sorafenib

Regorafenib in management 0:07:41

Regorafenib in management of colorectal cancer – Video abstract [ID 88825]

Dr. Bendell on 0:01:08

Dr. Bendell on FDA Approval of Regorafenib in Liver Cancer